|Bid||4.10 x 500|
|Ask||4.19 x 11900|
|Day's range||3.95 - 4.15|
|52-week range||3.67 - 7.67|
|PE ratio (TTM)||N/A|
|Earnings date||7 May 2018 - 11 May 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.08|
On a per-share basis, the Leawood, Kansas-based company said it had a loss of 37 cents. Losses, adjusted for asset impairment costs, came to 19 cents per share. The results surpassed Wall Street expectations. ...
NEW YORK, Jan. 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Enbridge Energy Management LLC (NYSE:EEQ), Glacier Bancorp, Inc. (NASDAQ:GBCI), Energous Corporation (NASDAQ:WATT), Aratana Therapeutics, Inc. (NASDAQ:PETX), Destination Maternity Corporation (NASDAQ:DEST), and Super Micro Computer, Inc. (NASDAQ:SMCI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Eli Lilly (LLY) animal health unit Elanco and partner Aratana announce the EU approval of Galliprant for treatment of pain associated with osteoarthritis in dogs.
Two specialized small-cap drug developers, and a financial holding company share similar traits to software giant Microsoft from three decades ago.
On a per-share basis, the Leawood, Kansas-based company said it had a loss of 21 cents. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...